Axsome Therapeutics AXSM
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 182.64 | -0.55 | -36,025 | -29 | ||
| 2025Q3 | 121.45 | -0.95 | -46,109 | -47 | ||
| 2025Q2 | 104.39 | 77.95 | -0.96 | -36,714 | -48 | |
| 2025Q1 | 116.63 | -1.22 | -56,982 | -59 | ||
| 2024Q4 | 84.61 | -1.54 | -72,617 | -75 | ||
| 2024Q3 | 89.87 | -1.34 | -62,624 | -65 | ||
| 2024Q2 | 80.50 | -1.67 | -78,046 | -79 | ||
| 2024Q1 | 79.80 | -1.44 | -67,275 | -68 | ||
| 2023Q4 | 79.59 | -2.13 | -98,274 | -99 | ||
| 2023Q3 | 69.89 | -1.34 | -62,120 | -62 | ||
| 2023Q2 | 71.86 | -1.54 | -65,057 | -67 | ||
| 2023Q1 | 61.68 | -0.26 | -6,374 | -11 | ||
| 2022Q4 | 77.13 | -1.43 | -59,918 | -61 | ||
| 2022Q3 | 44.62 | -1.08 | -42,412 | -45 | ||
| 2022Q2 | 38.30 | -1.06 | -39,181 | -41 | ||
| 2022Q1 | 41.39 | -1.03 | -38,289 | -40 | ||
| 2021Q4 | 37.78 | -0.90 | -32,608 | -34 | ||
| 2021Q3 | 32.96 | -0.93 | -33,407 | -35 | ||
| 2021Q2 | 67.46 | -0.86 | -30,848 | -32 | ||
| 2021Q1 | 56.62 | -0.78 | -27,844 | -29 |